Answer
Nov 21, 2024 - 01:31 PM
Briviact (brivaracetam) is considered an effective medication for the treatment of partial-onset seizures in patients with epilepsy, often used as an adjunctive therapy. Its efficacy and tolerability have been supported by clinical studies, and it is generally well-received by patients. However, like any medication, its suitability can vary based on individual patient needs and medical history, so it is important to consult a healthcare professional for personalized advice.
